What this means
This review pulls together recent and older studies on how aging blood vessels may fuel heart disease. It does not test a treatment, and it points to ideas still being studied.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A review of recent and older studies, plus some mouse and lab work
- Kind of research
- A study
The science
- Original title
- The triad of vascular ageing: Cellular senescence, inflammaging, and epigenetic remodelling in atherosclerosis.
- Authors
- Dabravolski SA, Borodko DD, Antonov SA et al.
- Journal
- Mechanisms of ageing and development
- Published
- Oct 16, 2026
- Study type
- Study
- PMID
- 42887676 ↗
Abstract
Atherosclerotic cardiovascular disease remains a leading global cause of the cardiovascular mortality burden, yet traditional lipid-centric models fail to explain the residual cardiovascular risk observed in older populations. This review, synthesising contemporary literature from 2020 onwards alongside foundational studies, explores the paradigm shift towards the 'geroscience hypothesis', positing that intrinsic biological ageing of the vascular wall is a potent amplifier and primary driver of atherogenesis acting in synergy with circulating lipids. We delineate a pathogenic triad: cellular senescence, systemic inflammaging, and epigenetic dysregulation. At the cellular level, mechanical and metabolic stressors force endothelial and vascular smooth muscle cells into a usually stable senescent state, triggering the Senescence-Associated Secretory Phenotype. Immunologically, ASCVD in the elderly is driven by metabolically exhausted macrophages, the emergence of clonal haematopoiesis of indeterminate potential, and cytotoxic memory T cells. Crucially, metabolic stressors such as hyperglycaemia induce long-lasting alterations to the chromatin landscape of haematopoietic stem cells, establishing 'trained immunity' and a persistent pro-inflammatory metabolic memory. These processes are deeply governed by an altered epigenetic landscape, including the loss of protective sirtuins and aberrant RNA methylation, which dynamically accelerate biological clocks like GrimAge. Clinically, vascular ageing trajectories are highly sexually dimorphic and heavily influenced by midlife metabolic clustering and endocrine shifts and murine models suggest highly sexually dimorphic plaque immunophenotypes. Finally, we evaluate the translational frontier of precision senotherapeutics. We contrast senomorphics, such as repurposed metformin and natural polyphenols that suppress the SASP, with targeted senolytics. Emerging nanotechnology-including in vivo CAR-T lipid nanoparticles and responsive peptide nanoassemblies-offers preclinical proof-of-concept strategies to selectively clear senescent cells without systemic toxicity. Ultimately, mitigating ASCVD requires moving beyond lipid management to integratively target the biological clock of the artery.
Dabravolski SA, Borodko DD, Antonov SA et al. The triad of vascular ageing: Cellular senescence, inflammaging, and epigenetic remodelling in atherosclerosis. Mechanisms of ageing and development. 2026. doi:10.1016/j.mad.2026.112267. PMID: 42887676. https://pubmed.ncbi.nlm.nih.gov/42887676/
Related research
New fluorescent sensor detects cells aging from cancer and lung drugs
Researchers built a glowing probe that lights up only in certain aged cells. It may help scientists track these cells in living animals, but this is early lab work.
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Neuronal receptor remodeling in the aging periosteum: From single-cell atlases to regenerative targets.
The periosteum is the most densely innervated compartment of the skeleton and harbors periosteal stem cells expressing a broad repertoire of neuronal receptors traditionally associated with the nervous system.
A vaccine-style treatment in mice eased diabetes signs and aged cell markers
Mice given a treatment aimed at a virus-like gene showed less weight gain and better blood sugar control. This study was in mice and cells, so it does not show the same would happen in people.
Aging cells that support stem cells may disrupt them through chemical signals
This is a review that pulls together older and newer studies. It proposes a model, but it does not show that the model is true.
Cx43 protein may boost breast cancer drug response in lab tests
Researchers studied a protein called Cx43 that helps cells talk to each other. They found it may help a breast cancer drug slow tumor growth. This early work is not yet checked by other scientists, so it does not show this would help people.
See all research on Metformin →